DVA Form 4: Adam Schechter Reports 369-Share Acquisition
Rhea-AI Filing Summary
DaVita Inc. director Adam H. Schechter reported a non-derivative acquisition of company stock on 08/15/2025. The filing shows 369 shares were acquired with a reported price of $0, leaving the reporting person with 4,699 shares beneficially owned. The Form 4 was signed by an attorney-in-fact on 08/19/2025. No derivative transactions or additional remarks are reported in the filing.
Positive
- Insider acquisition reported: Director Adam H. Schechter acquired 369 shares, increasing beneficial ownership to 4,699 shares.
- Clear, timely disclosure: The Form 4 was signed and filed, satisfying Section 16 reporting requirements.
Negative
- None.
Insights
TL;DR: Routine insider stock grant reported; no derivatives or unusual dispositions.
The Form 4 documents a straightforward non-derivative acquisition of 369 shares by a director, increasing beneficial ownership to 4,699 shares. The $0 price suggests these shares were granted rather than purchased, though the form provides no plan or grant agreement details. This is a standard disclosure under Section 16 and does not, on its face, indicate any change in control or material shift in governance.
TL;DR: Small, routine insider share acquisition with limited market impact.
The transaction size is small relative to a public company and no derivatives were reported. The filing contains no additional financial metrics or contextual information about timing or vesting. For investors, this filing confirms insider ownership levels but does not provide material new information affecting valuation.
FAQ
What transaction did Adam H. Schechter report on Form 4 for DVA?
How many DaVita (DVA) shares does the reporting person own after the transaction?
What price was reported for the acquired shares in the DVA Form 4?
Were any derivative securities reported in this DVA Form 4?
When was the Form 4 for this DVA transaction signed?